Here's what you need to know before you toss out your old computers. Walter Zerla/Getty Images

It's important for all companies to take certain factors into consideration before they get rid of their excess electronics. I've worked in the technology industry for over 20 years, helping customers across all industries ensure the proper and secure disposal of their equipment. I specifically want Houston businesses to be aware of some of the less-obvious facts when it comes to electronics recycling and disposal — and for them to know that trusted, locally based IT asset disposition (ITAD) services are available.

The world produces 40 million tons of e-waste annually, and only 20 percent of that is being disposed of properly.

Electronic waste and its environmental effects are a serious global issue. When businesses go through technology refreshes, much of their equipment ends up sitting in landfills; this can be avoided, though. Like other widely used materials, such as glass, paper, and plastic, excess electronics and their parts can be recycled, too.

Law firms, health centers, financial institutions, and many other types of businesses aren't necessarily expected to break down electronics and recycle pieces themselves. All businesses, though, are obligated to work with a trusted IT asset disposition partner when disposing of or replacing electronic equipment to ensure that best practices for removal are followed.

Recycling and disposal experience matter when it comes to ensuring compliance with federal and environmental laws. 

Major countries around the globe, including the United States, have implemented strict recycling laws. Especially in recent years, the federal government has placed a heavy emphasis on proper electronics disposal practices. New tech products and their upgraded versions are released constantly, replacing older equipment with the latest and greatest.

For businesses, technology refreshes are often large-scale, requiring a major equipment overhaul. When mass amounts of products are left to contend with, it's easy (and common) to overlook key details. It is important to note that some environmental laws will vary by state and even by city ordinance.

Companies should partner with an ITAD professional that prioritizes reliability and is certified to a recognized, international recycling standard. e-Stewards certification offers a great example of globally responsible recycling practices that operate in accordance with specific laws. The right ITAD partner can help companies protect their overall brand integrity while staying in compliance with recycling laws.

The only way to ensure that sensitive information is safely eliminated is to wipe or shred drives.   

The rise of data breaches in the U.S. — both small and large — is concerning. Breaches often take place because hardware is handled improperly. Technology refreshes are very common, usually occurring about every two to five years for businesses.

Across office spaces, millions of megabytes of data are stored on employees' equipment. All devices, from PCs to desk phones, house potentially sensitive company information. The drives in computers are usually most at risk for compromising data. Fortunately, data can be safely removed by wiping information off the hardware or shredding it to unrestorable size.

Value can be recovered from excess electronics. 

Depending on the equipment and hardware specifications, some electronics can be remarketed as whole products or sold for their individual parts. Excess electronics are often resold at a small percentage of their original purchase price, though. But, when monetary value can be recovered from parts, companies can invest recouped revenues into new equipment.

The secondary market for excess IT equipment is quite large. Partnering with an ITAD professional that has the right network and connections can help customers achieve maximum return on investment for their equipment.

Local, on-site disposal solutions are conveniently available.  

Proper electronics recycling is easy when you partner with a trusted, experienced IT asset disposition professional. Instead of having product shipped to warehouses, companies can elect for disposal solutions to come to them. Shred trucks can wipe and destroy data off of about a thousand hard drives or SSDs per hour.

Serving as an extension of an ITAD professional's warehouse, shred trucks offer the same quality of services, but are fully mobile. On-site data sanitization services, complete with certificates of wiping and destruction, can be included. A company's IT equipment can be securely removed and documented without ever having to leave its premises.

As a facilities manager, IT supervisor, CTO, or CIO, if you don't already have a technology recycling program in place, you should start assessing your needs. If you do have an IT asset disposition program in place, make sure your partner is thoroughly qualified. The five disposal facts I've listed should serve as a guidepost for industry best practices.

------

Ed Wooten is Smith's director of ITAD, or IT asset disposition.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.